Trial intelligence / Profile preview

Dexmethylphenidate for Chemotherapy-Related Fatigue in Cancer Patients

NCT00047476Phase 2Completed

Sponsor
Celgene Corporation
Start
Jun 2002
Countries
1
01

Overview

A Phase 2 trial of dexmethylphenidate in fatigue, sponsored by Celgene Corporation. Started Jun 2002; status: completed.

02

Drugs

dexmethylphenidate
03

Conditions

fatigue

Beyond the preview

Go deeper on NCT00047476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00047476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call